Year: 2026
Type: preprint
Study design: Observational Study
Abstract: Systemic antibody responses are more strongly associated with protection against severe COVID-19 in the lung than with protection against SARS-CoV-2 infection in the upper airway. To define the immunological basis of this divergence, we performed contemporaneous sampling of blood, nasal lining fluid (NLF), and bronchoalveolar lavage (BAL) fluid in HIV-uninfected adults and antiretroviral therapy (ART)-treated people with HIV (PWH). Serum spike-specific IgG antibodies correlated more strongly with BAL than with NLF across multiple variants of concern and were not confounded by HIV status. In contrast, IgA drove ACE2–spike inhibition activity in NLF, and this was not predicted by systemic or LRT antibodies. SARS-CoV-2–specific CD4⁺ and CD8⁺ T cells were enriched in BAL, exhibited tissue-resident phenotypes, and did not correlate with circulating T cells, even in ART-treated PWH. Together, these findings could provide an immunological basis for why systemic antibody responses reliably correlate with protection against lung disease but poorly predict nasal immunity.
Source: Research Square
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7214643282
